Detalles de la búsqueda
1.
The addition of vorinostat to lenalidomide maintenance for patients with newly diagnosed multiple myeloma of all ages: results from 'Myeloma XI', a multicentre, open-label, randomised, phase III trial.
Br J Haematol
; 201(2): 267-279, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36541152
2.
Thrombosis in patients with myeloma treated in the Myeloma IX and Myeloma XI phase 3 randomized controlled trials.
Blood
; 136(9): 1091-1104, 2020 08 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-32438407
3.
Carfilzomib, lenalidomide, dexamethasone, and cyclophosphamide (KRdc) as induction therapy for transplant-eligible, newly diagnosed multiple myeloma patients (Myeloma XI+): Interim analysis of an open-label randomised controlled trial.
PLoS Med
; 18(1): e1003454, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33428632
4.
Optimising the value of immunomodulatory drugs during induction and maintenance in transplant ineligible patients with newly diagnosed multiple myeloma: results from Myeloma XI, a multicentre, open-label, randomised, Phase III trial.
Br J Haematol
; 192(5): 853-868, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32656799
5.
Lenalidomide before and after autologous stem cell transplantation for transplant-eligible patients of all ages in the randomized, phase III, Myeloma XI trial.
Haematologica
; 106(7): 1957-1967, 2021 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32499244
6.
Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma.
Blood
; 132(6): 587-597, 2018 08 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29884741
7.
Microhomology-mediated end joining drives complex rearrangements and overexpression of MYC and PVT1 in multiple myeloma.
Haematologica
; 105(4): 1055-1066, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31221783
8.
Transcriptome-wide association study of multiple myeloma identifies candidate susceptibility genes.
Hum Genomics
; 13(1): 37, 2019 08 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-31429796
9.
Lenalidomide maintenance versus observation for patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 20(1): 57-73, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30559051
10.
Clonal evolution in myeloma: the impact of maintenance lenalidomide and depth of response on the genetics and sub-clonal structure of relapsed disease in uniformly treated newly diagnosed patients.
Haematologica
; 104(7): 1440-1450, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30733268
11.
Quality of life during and following sequential treatment of previously untreated patients with multiple myeloma: findings of the Medical Research Council Myeloma IX randomised study.
Br J Haematol
; 182(6): 816-829, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29984830
12.
Serum free light chain levels and renal function at diagnosis in patients with multiple myeloma.
BMC Nephrol
; 19(1): 178, 2018 07 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-30012107
13.
Active multiple myeloma suppresses and typically eliminates coexisting MGUS.
Br J Cancer
; 117(6): 835-839, 2017 Sep 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28728165
14.
Telomere length is a critical determinant for survival in multiple myeloma.
Br J Haematol
; 178(1): 94-98, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28342200
15.
Minimal residual disease in myeloma by flow cytometry: independent prediction of survival benefit per log reduction.
Blood
; 125(12): 1932-5, 2015 Mar 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-25645353
16.
Coexistent hyperdiploidy does not abrogate poor prognosis in myeloma with adverse cytogenetics and may precede IGH translocations.
Blood
; 125(5): 831-40, 2015 Jan 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-25428216
17.
The spectrum of somatic mutations in monoclonal gammopathy of undetermined significance indicates a less complex genomic landscape than that in multiple myeloma.
Haematologica
; 102(9): 1617-1625, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28550183
18.
Serum free immunoglobulin light chain evaluation as a marker of impact from intraclonal heterogeneity on myeloma outcome.
Blood
; 123(22): 3414-9, 2014 May 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-24733348
19.
A molecular diagnostic approach able to detect the recurrent genetic prognostic factors typical of presenting myeloma.
Genes Chromosomes Cancer
; 54(2): 91-8, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25287954
20.
Real-world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID-19 disease) in patients with multiple myeloma receiving systemic anti-cancer therapy.
Br J Haematol
; 190(2): e83-e86, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32438482